Home » Newsletters » BioWorld Asia

BioWorld Asia

May 26, 1999

View Archived Issues

TAB, Proteus Will Merge To Form #63M Company

Protein Discovery Could Lead To Oxygen-Sensing Answers

Evotec, Qiagen Form Venture For Nucleic Acid Systems

Chiroscience Finds Bone Gene With Osteoporosis Implications

BresaGens IPO Will Help Fund Work In Stem Cells

Phase II Trials Under Way For Xenovas XR9576 Drug

XTLs Trimera HBV Mouse Model Demonstrates Antiviral Efficacy

Israel Seeks European Partners

Oxford Biomedica Partners With Korean Gene Therapy Company

Biotech Salmon In The Pink

Celltech On Track To File U.S. NDA In Third Quarter

Alizyme Gets OK For Phase II On Renzapride

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.